Trial Design Solutions

1. The Patient Layer Of Clinical Intelligence Is Here 10/14/2026

   To build a full view of the patient, sponsors and CROs have had to piece together data from many disconnected sources. How can you assemble those insights in one connected view?

2. Comprehensive Services For Ophthalmology Drug Development 1/26/2023

   As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.

3. Delivering Precise, Reliable Data For Your Schizophrenia Research 8/5/2026

   Struggling with rater consistency or endpoint selection in your schizophrenia trial? Learn how deep neuroscience expertise safeguards data quality and drives faster decisions.

4. Why Central IRBs Matter For Efficient Clinical Trials 4/10/2025

   “Going the extra mile is a big part of our DNA. Personal attention can go a long way in ensuring the success of your next research study.”

   Raffaella Hart, MS, CIP
   Sr. Vice President, IRB and IBC Services

   Fast, reliable IRB review for multisite studies backed by expert oversight and responsive support. With streamlined submissions, frequent meetings, and dedicated client managers, BRANY IRB helps you save time and money while maintaining full regulatory compliance.

5. Special And Patient Populations 1/26/2023

   Altasciences has the advanced level of clinical expertise required to successfully recruit and conduct clinical trials involving special and patient populations.

6. Medical Writing: A Collaborative Approach 7/31/2024

   Discover how a collaborative approach to medical writing ensures the highest standards of excellence and precision in every document produced.

7. A Data-Driven And Transparent Approach To Vaccine Research 8/7/2026

   Looking for faster trial startup, diverse participant pools, and consistent site quality? Explore a vaccine research network designed to keep your study on time and on target.

8. Your Top Partner For Ophthalmic Drug Development 4/9/2024

   As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.

9. Deliver Supply Without Friction. Maintain Control At Every Step 7/30/2026

   Learn how clinical supply organizations can reduce manual effort, strengthen compliance, improve global coordination, and maintain control across evolving clinical trial supply chains. 

10. Human Abuse Potential 4/17/2024

    With over 60 HAP studies successfully conducted in the last decade, Altasciences has experience in diverse areas such as for stimulants, opioids, and sedative-hypnotics.